Literature DB >> 15735401

Mesenchymal stem cells in the infarcted heart.

Mohit Jain1, Otmar Pfister, Roger J Hajjar, Ronglih Liao.   

Abstract

A loss of functional cardiomyocytes forms the cellular basis of cardiac dysfunction and heart failure. Stem cell based repletion of scarred myocardial tissue and regeneration of cardiomyocytes have been proposed as a potential treatment of ventricular dysfunction. In this review, we provide an overview of recent studies utilizing mesenchymal stem cells in cardiac regeneration and post-myocardial infarct therapy.

Entities:  

Mesh：

Year:  2005        PMID： 15735401     DOI： 10.1097/00019501-200503000-00003

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN： 0954-6928            Impact factor:   1.439


  10 in total

1.  Aortic implantation of mesenchymal stem cells after aneurysm injury in a porcine model.

Authors:  Irene C Turnbull; Lahouaria Hadri; Kleopatra Rapti; Mikel Sadek; Lifan Liang; Hyun J Shin; Kevin D Costa; Michael L Marin; Roger J Hajjar; Peter L Faries
Journal:  J Surg Res       Date:  2011-07-13       Impact factor: 2.192

2.  Comparative study of three types of polymer materials co-cultured with bone marrow mesenchymal stem cells for use as a myocardial patch in cardiomyocyte regeneration.

Authors:  Hongxing Niu; Junsheng Mu; Jianqun Zhang; Ping Hu; Ping Bo; Yan Wang
Journal:  J Mater Sci Mater Med       Date:  2013-04-26       Impact factor: 3.896

3.  Accelerated stem cell labeling with ferucarbotran and protamine.

Authors:  Daniel M Golovko; Tobias Henning; Jan S Bauer; Marcus Settles; Thomas Frenzel; Artur Mayerhofer; Ernst J Rummeny; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2009-09-12       Impact factor: 5.315

4.  Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells.

Authors:  Tobias D Henning; Michael F Wendland; Daniel Golovko; Elizabeth J Sutton; Barbara Sennino; Farbod Malek; Jan S Bauer; Donald M McDonald; Heike Daldrup-Link
Journal:  Magn Reson Med       Date:  2009-08       Impact factor: 4.668

Review 5.  Cardiac stem cells: biology and clinical applications.

Authors:  Polina Goichberg; Jerway Chang; Ronglih Liao; Annarosa Leri
Journal:  Antioxid Redox Signal       Date:  2014-04-10       Impact factor: 8.401

6.  Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction.

Authors:  Yefei Li; Yuyu Yao; Zulong Sheng; Yanxiaoxiao Yang; Genshan Ma
Journal:  Int J Nanomedicine       Date:  2011-04-19

7.  Aging increases the susceptivity of MSCs to reactive oxygen species and impairs their therapeutic potency for myocardial infarction.

Authors:  Liang Li; Yingfei Guo; Hongxia Zhai; Yaxin Yin; Jinjin Zhang; Haiwei Chen; Lei Wang; Na Li; Runmei Liu; Yunfeng Xia
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

8.  Role of alternative polyadenylation during adipogenic differentiation: an in silico approach.

Authors:  Lucía Spangenberg; Alejandro Correa; Bruno Dallagiovanna; Hugo Naya
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

9.  Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up.

Authors:  Sander F Rodrigo; Jan van Ramshorst; Georgette E Hoogslag; Helèn Boden; Matthijs A Velders; Suzanne C Cannegieter; Helene Roelofs; Imad Al Younis; Petra Dibbets-Schneider; Willem E Fibbe; Jaap Jan Zwaginga; Jeroen J Bax; Martin J Schalij; Saskia L Beeres; Douwe E Atsma
Journal:  J Cardiovasc Transl Res       Date:  2013-08-28       Impact factor: 4.132

10.  Angiogenic Potential of Bone Marrow Derived CD133+ and CD271+ Intramyocardial Stem Cell Trans- Plantation Post MI.

Authors:  Sarah Sasse; Anna Skorska; Cornelia Aquilina Lux; Gustav Steinhoff; Robert David; Ralf Gaebel
Journal:  Cells       Date:  2019-12-27       Impact factor: 6.600
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.